Senior couples may be in the winter of their lives, but the heat of the summer could still be lingering inside them, many ...

Frame design influences critical parameters such as radial strength, flexibility, fatigue resistance and conformability to ...

Prenatal exposure to PFAS, known as "forever chemicals," was linked to higher blood pressure (BP) during adolescence in a ...

That said, patients aged 65-69 who underwent early TAVR derived the most benefits, with significant reduction in stroke risk (0% early TAVR vs. 13% CS) and had six times lower rate of death ...

DENVER--(BUSINESS WIRE)--Transverse Medical Inc., a leading innovator in Cerebral Embolic Protection for stroke prevention during TAVR (Transcatheter Aortic Valve Replacements) and early-stage ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in ...

While TAVR carries a good safety record overall, around 2% to 4% of patients have a stroke during or shortly after the procedure, sometimes because calcium or tissue fragments are released when ...

Among patients assigned to TAVR and clinical surveillance, death occurred in 8.4% and 9.2%, respectively; stroke in 4.2% and 6.7%; and unplanned hospitalization for cardiovascular causes in 20.9% ...

With a median follow up of 3.8 years, the data demonstrated superiority of early TAVR, with 26.8% of the 455 patients in the TAVR arm experiencing death, stroke or unplanned cardiovascular ...

Impact of Cerebral Embolic Protection Devices on Disabling Stroke after Transcatheter Aortic Valve Replacement: Updated Results from the STS/ACC TVT Registry. Circulation: ...

The disabling stroke endpoint was separately validated in a population pooling data from PARTNER 2A, PARTNER 3, the Sapien S3i Registry, SURTAVI, Evolut Low Risk, and PROTECTED TAVR -- with ...

Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated with substantial decreased rates of death or stroke at one year in low-risk patients ...